| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |